MICROBA LIFE SCIENCES LTD(MAP.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

MAP.AU MICROBA LIFE SCIENCES LTD

Trading 06-28 10:37:11 AEST

0.17

+0.00

0.00%

High0.17	Low0.17	Vol111.89K
Open0.17	D1 Closing0.17	Amplitude3.03%
Mkt Cap73.90M	Tradable Cap38.77M	Total Shares447.85M
T/O18.60K	T/O Rate0.05%	Tradable Shares235.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MAP.AU","market":"AU","secType":"STK","nameCN":"MICROBA LIFE SCIENCES LTD","latestPrice":0.165,"timestamp":1719534523563,"preClose":0.165,"halted":0,"volume":111886,"delay":0,"nameEN":"MICROBA LIFE SCIENCES LTD","floatShares":234998322,"shares":447851977,"eps":-0.051812,"marketStatus":"Trading","change":0,"latestTime":"06-28 10:37:11 AEST","open":0.17,"high":0.17,"low":0.165,"amount":18604,"amplitude":0.030303,"askPrice":0.165,"askSize":59308,"bidPrice":0.155,"bidSize":53560,"shortable":3,"etf":0,"ttmEps":-0.051812,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1719554400000},"marketStatusCode":2,"adr":0,"listingDate":1648994400000,"exchange":"ASX","adjPreClose":0.165,"openAndCloseTimeList":[[1719532800000,1719554400000]],"volumeRatio":2.396977,"lotSize":0,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/MAP.AU/tweets","defaultTab":"tweets","newsList":[{"id":"2441577458","title":"Insiders Give Up AU$119k As Microba Life Sciences Stock Drops To AU$0.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2441577458","media":"Simply Wall St.","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2441577458?lang=en_us&edition=fundamental","pubTime":"2024-06-07 04:49","pubTimestamp":1717706996,"startTime":"0","endTime":"0","summary":"The recent 10.0% drop in Microba Life Sciences Limited's ( ASX:MAP ) stock could come as a blow to insiders who...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-map/microba-life-sciences-shares/news/insiders-give-up-au119k-as-microba-life-sciences-stock-drops","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MAP.AU","BK7124"],"gpt_icon":0},{"id":"2431587457","title":"1 ASX dividend stock to buy that's down 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431587457","media":"MotleyFool","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2431587457?lang=en_us&edition=fundamental","pubTime":"2024-04-30 07:41","pubTimestamp":1714434064,"startTime":"0","endTime":"0","summary":"The ASX dividend stock Sonic Healthcare Ltd  has seen its fair share of pain over the last few years, despite the ongoing growth of the underlying business.ASX healthcare shares can be appealing for dividends because they typically have fairly consistent demand – people don't choose when to get sick or when to require healthcare.It's understandable why Sonic has fallen from its peak in 2021 – the number of COVID-19 tests being done have dramatically reduced. Sonic was one of the key businesses doing tests in laboratories during 2020, 2021 and 2022.Its main business operations provides pathology services in multiple countries such as Australia, the US, the UK, Germany and Switzerland.Appealing core business for this ASX dividend stock. One of the main things I want to see from any potential ASX dividend stock investment is good operational growth from the main business. This can help maintain and grow the existing dividend.The ASX dividend stock has a stated progressive dividend policy.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/30/1-asx-dividend-stock-to-buy-thats-down-40/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SCS","BK7124","SHL.AU","MAP.AU","BK4143"],"gpt_icon":0},{"id":"2429413383","title":"BUZZ-Australia's Microba Life Sciences gains most in two weeks on Q3 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2429413383","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2429413383?lang=en_us&edition=fundamental","pubTime":"2024-04-23 10:35","pubTimestamp":1713839739,"startTime":"0","endTime":"0","summary":"** Shares of Australia's Microba Life Sciences    rise as much as 8.8% to A$0.185, marking its biggest intraday pct gain since April 9   ** Stock trims some gains to last trade at 7.4%   ** Precision microbiome co posts Q3 unaudited revenue of A$4 mln , up 82% Q/Q    ** Stock down 5.6% YTD, as of last close   ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XJO.AU","BK7124","XKO.AU","MAP.AU","XAO.AU"],"gpt_icon":0},{"id":"2429187113","title":"BRIEF-Microba Life Sciences Says A$4.00M In Q3 FY24 Unaudited Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2429187113","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2429187113?lang=en_us&edition=fundamental","pubTime":"2024-04-23 09:53","pubTimestamp":1713837226,"startTime":"0","endTime":"0","summary":"April 23 (Reuters) - Microba Life Sciences Ltd   :   * A$4.00M IN Q3 FY24 UNAUDITED REVENUE, UP 297% YOYFurther company coverage:","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU"],"gpt_icon":0},{"id":"2427093823","title":"Why this ASX 200 stock is a retiree's dream","url":"https://stock-news.laohu8.com/highlight/detail?id=2427093823","media":"MotleyFool","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2427093823?lang=en_us&edition=fundamental","pubTime":"2024-04-15 08:13","pubTimestamp":1713140014,"startTime":"0","endTime":"0","summary":"Sonic Healthcare Ltd (ASX: SHL) looks to me like a leading S&P/ASX 200 Index (ASX: XJO) stock to own in retirement. The ASX healthcare share is a global pathology business with operations in Australia","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/15/why-this-asx-200-stock-is-a-retirees-dream/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["MAP.AU","XJO.AU","BK7124","SHL.AU"],"gpt_icon":0},{"id":"2426121384","title":"Positive Signs As Multiple Insiders Buy Microba Life Sciences Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2426121384","media":"Simply Wall St.","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2426121384?lang=en_us&edition=fundamental","pubTime":"2024-04-10 04:47","pubTimestamp":1712695675,"startTime":"0","endTime":"0","summary":"It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Microba Life Sciences Limited's  case, it's fantastic news for shareholders.Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.View our latest analysis for Microba Life Sciences. The Last 12 Months Of Insider Transactions At Microba Life Sciences. In the last twelve months, the biggest single purchase by an insider was when Non-Executive Director Richard Bund bought AU$450k worth of shares at a price of AU$0.23 per share. That means that an insider was happy to buy shares at above the current price of AU$0.20. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/positive-signs-multiple-insiders-buy-204755088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2423741792","title":"Press Release: Arbor Realty Trust Declares Preferred Stock Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2423741792","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2423741792?lang=en_us&edition=fundamental","pubTime":"2024-03-30 04:15","pubTimestamp":1711743300,"startTime":"0","endTime":"0","summary":"UNIONDALE, N.Y., March 29, 2024  -- Arbor Realty Trust, Inc. , today announced that its Board of Directors has declared cash dividends on the Company's Series D, Series E, and Series F cumulative redeemable preferred stock of $0.3984375, $0.390625, and $0.390625 per share, respectively. The Series D, E, and F preferred stock dividends reflect accrued dividends from January 30, 2024 through April 29, 2024. The dividends are payable on April 30, 2024 to preferred stockholders of record on April 15, 2024.Arbor Realty Trust, Inc.  is a nationwide real estate investment trust and direct lender, providing loan origination and servicing for multifamily, single-family rental  portfolios, and other diverse commercial real estate assets. Headquartered in New York, Arbor manages a multibillion-dollar servicing portfolio, specializing in government-sponsored enterprise products. Arbor is a leading Fannie Mae DUS lender and Freddie Mac Optigo Seller/Servicer, and an approved FHA Multifamily Acceler","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","ABR","BK4110","MAP.AU","R","SFR.AU","BK4022","BK7507","BK4232","BK7506","BK7110"],"gpt_icon":0},{"id":"2420898817","title":"1 ASX healthcare stock that looks severely undervalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2420898817","media":"MotleyFool","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2420898817?lang=en_us&edition=fundamental","pubTime":"2024-03-20 05:30","pubTimestamp":1710883800,"startTime":"0","endTime":"0","summary":"I think the ASX healthcare stock Sonic Healthcare Ltd  looks very undervalued. It's so cheap that I'm thinking about buying some Sonic Healthcare shares myself.The Sonic Healthcare share price has fallen more than 15% in the past year and it's down around 25% since April 2023.This global pathology business is one to look into, in my opinion.I love investing in growing businesses where the share price has dropped because this means the price/earnings (P/E) ratio has reduced and is usually more attractive.The ASX healthcare stock also said its cost reduction programs are \"well advanced\", which could be beneficial for margins in future reporting periods.Due to its fairly large market capitalisation size, I'm not expecting huge gains, but I believe it can be a steady compounder and outperform the S&P/ASX 200 Index  over the long term, at the current Sonic Healthcare share price. I'm thinking about buying some Sonic Healthcare shares for my own portfolio at the current level when Motley Foo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/03/20/1-asx-healthcare-stock-that-looks-severely-undervalued/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SHL.AU","MAP.AU","BK7124","XJO.AU"],"gpt_icon":0},{"id":"2420621881","title":"ASX 200 rises on RBA hold and BOJ hike as iron ore rally boosts BHP, RIO & FMG","url":"https://stock-news.laohu8.com/highlight/detail?id=2420621881","media":"LiveWire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2420621881?lang=en_us&edition=fundamental","pubTime":"2024-03-19 16:09","pubTimestamp":1710835798,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200  finished 27.4 points higher at 7,703.2, 0.47% from its session low and just 0.06% from its high/low. It was the second day of near-total-balance between advancers and decliners in the broader-based S&P/ASX 300  at 138 a piece. Clearly, despite two modest days of gains, indecision reigns.The Resources   sector was the best performing sector today, likely in response to rising prices of iron ore, aluminium, copper, and tin. We've been all over the developments in these markets in Evening Wrap, and there's a follow up on the bouncing iron ore price in ChartWatch below. BHP Group  , Rio Tinto  , and Fortescue   each enjoyed solid daily gains.It's been a great start to the week for ASX resources stocks. Also doing well today were the Energy   sector and the Gold   sub-index. The price of gold has only edged higher, but gold stocks were likely helped by the broader resources rally. On the other hand, WTI crude oil did log a solid gain on Monday – and that's three out of four","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/asx-200-rises-on-rba-hold-and-boj-hike-as-iron-ore-rally-boosts-bhp-rio-fmg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/asx-200-rises-on-rba-hold-and-boj-hike-as-iron-ore-rally-boosts-bhp-rio-fmg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BHP.AU","MAH.AU","TER.AU","TLG.AU","A4N.AU","BGL.AU","PEN.AU","PPS.AU","SGP.AU","BKT.AU","MAP.AU","BRG","RMC.AU","BBN","BBN.AU","MZZ","NVX","CLW","CTT.AU","NSR.AU","XJR","BRG.AU","VUL.AU","WR1.AU","ABG","SLC.AU","OBL.AU","GOZ.AU","KGN.AU","MAQ.AU","C79.AU","NIC","NVX.AU","SUN","XKO.AU","LIC.AU","MZZ.AU","FMG.AU","MGR","PEN","APX.AU","LRS.AU","SXE.AU","GQG.AU","DXS.AU","ASK.AU","BHP","BKT","GMG.AU","CQR.AU"],"gpt_icon":0},{"id":"2420232229","title":"Microba's Domestic Revenues to Get Boost From Sonic Partnership -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2420232229","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2420232229?lang=en_us&edition=fundamental","pubTime":"2024-03-19 06:57","pubTimestamp":1710802620,"startTime":"0","endTime":"0","summary":"2257 GMT - Microba Life Sciences' domestic revenues will be boosted by the roll-out of its gastrointestinal infectious disease test via Sonic Healthcare, Bell Potter analyst Thomas Wakim says. He points out that ASX-listed pathology provider Sonic has put considerable effort into the launch of the so-called MetaPanel test, holding deep cross-organization training events and a nationwide series of launch events. He tells clients in a note that MetaPanel is differentiated by its ability to detect more than three times as many pathogens than existing competitor tests. Bell Potter keeps a buy rating and A$0.35 target price on the stock, which is at A$0.19 ahead of the open. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU","SHL.AU"],"gpt_icon":0},{"id":"2414359263","title":"BRIEF-Microba Life Sciences Posts H1 Revenue Result Of A$3.27M","url":"https://stock-news.laohu8.com/highlight/detail?id=2414359263","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2414359263?lang=en_us&edition=fundamental","pubTime":"2024-02-28 09:32","pubTimestamp":1709083963,"startTime":"0","endTime":"0","summary":"Feb 28 (Reuters) - Microba Life Sciences Ltd   :   * H1 REVENUE RESULT OF A$3.27M, UP 52% YOY   * LOSS FOR HALF-YEAR ATTRIBUTABLE A$11.5 MILLIONSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU"],"gpt_icon":0},{"id":"2411530645","title":"Insiders Give Up AU$259k As Microba Life Sciences Stock Drops To AU$0.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2411530645","media":"Simply Wall St.","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2411530645?lang=en_us&edition=fundamental","pubTime":"2024-02-15 04:40","pubTimestamp":1707943247,"startTime":"0","endTime":"0","summary":"Insiders who bought AU$683.5k worth of Microba Life Sciences Limited's ( ASX:MAP ) stock at an average buy price of...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-map/microba-life-sciences-shares/news/insiders-give-up-au259k-as-microba-life-sciences-stock-drops","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MAP.AU","BK7124"],"gpt_icon":0},{"id":"2409254541","title":"Microbia Life Sciences Offers Compelling Long-Term Opportunity -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2409254541","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2409254541?lang=en_us&edition=fundamental","pubTime":"2024-02-07 08:58","pubTimestamp":1707267480,"startTime":"0","endTime":"0","summary":"0058 GMT - Microbia Life Sciences looks undervalued to Morgans analyst Iain Wilkie, who sees it benefiting from healthcare professionals' increasing awareness of the importance of gut health. Initiating coverage of the stock with a speculative buy rating, Wilkie tells clients in a note that he likes the look of the global diagnostic partnerships established by Microbia, which specializes in gut-health testing and therapeutic development. ASX-listed Sonic Healthcare is a major shareholder. Microbia offers a compelling opportunity for long-term investors as it progresses clinical-stage drug development and the role of gut microbiome across a range of conditions is better understood, he reckons. Morgans places a A$0.35 target price on the stock, which is flat at A$0.165. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU","BK7124"],"gpt_icon":0},{"id":"2407825689","title":"BRIEF-Microba Life Sciences Says 1H Unaudited Revenue Totalled A$3.27M","url":"https://stock-news.laohu8.com/highlight/detail?id=2407825689","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2407825689?lang=en_us&edition=fundamental","pubTime":"2024-01-30 08:59","pubTimestamp":1706576350,"startTime":"0","endTime":"0","summary":"Jan 30 (Reuters) - Microba Life Sciences Ltd   :   * 1H FY24 UNAUDITED REVENUE TOTALLED A$3.27M, UP 52%Source text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.microba.com","stockEarnings":[{"period":"1week","weight":-0.0833},{"period":"1month","weight":-0.1538},{"period":"3month","weight":-0.2143},{"period":"6month","weight":-0.0833},{"period":"1year","weight":-0.4762},{"period":"ytd","weight":-0.0833}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0189},{"period":"3month","weight":0.0213},{"period":"6month","weight":0.0947},{"period":"1year","weight":0.1298},{"period":"ytd","weight":0.0947}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"exchange":"ASX","name":"MICROBA LIFE SCIENCES LTD","nameEN":"MICROBA LIFE SCIENCES LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MICROBA LIFE SCIENCES LTD(MAP.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MICROBA LIFE SCIENCES LTD(MAP.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MICROBA LIFE SCIENCES LTD,MAP.AU,MICROBA LIFE SCIENCES LTD股票,MICROBA LIFE SCIENCES LTD股票老虎,MICROBA LIFE SCIENCES LTD股票老虎国际,MICROBA LIFE SCIENCES LTD行情,MICROBA LIFE SCIENCES LTD股票行情,MICROBA LIFE SCIENCES LTD股价,MICROBA LIFE SCIENCES LTD股市,MICROBA LIFE SCIENCES LTD股票价格,MICROBA LIFE SCIENCES LTD股票交易,MICROBA LIFE SCIENCES LTD股票购买,MICROBA LIFE SCIENCES LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MICROBA LIFE SCIENCES LTD(MAP.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MICROBA LIFE SCIENCES LTD(MAP.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction